Sudeep Pharma

Sudeep Pharma IPO Review by Hem Securities; India's Burgeoning Pharmaceutical Excipients Ecosystem Offers Strong Growth Opportunity

K S Srinivasan 23 November 2025
Sudeep Pharma IPO Review by Hem Securities; India's Burgeoning Pharmaceutical Excipients Ecosystem Offers Strong Growth Opportunity

Hem Securities Research has issued a decisive "SUBSCRIBE" recommendation for Sudeep Pharma Limited's initial public offering, valuing the company at a price band of Rs 563-593 per share—representin